Inmune Bio announces pricing of $4.50 million registered direct offering and concurrent private placement
INMB•Inmune Bio announced pricing of a $4.50 million registered direct offering and concurrent private placement.
1. Offering pricing
Inmune Bio announced pricing of a $4.50 million registered direct offering and concurrent private placement.
